Hospira Reports First-Quarter 20...(-------- -------- Total Cur...),Health

Date:4/28/2009

-------- -------- Total Current Assets 2,202.3 2,149.3 -------- -------- Property and equipment, net 1,177.1 1,192.1 Intangible assets, net 388.9 404.4 Goodwill 1,157.6 1,167.4 Deferred income taxes 68.4 70.1 Investments 38.2 37.6 Other assets 53.2 53.2 -------- -------- Total Assets $5,085.7 $5,074.1 ======== ======== Liabilities and Shareholders' Equity Current Liabilities: Short-term borrowings $704.1 $338.3 Trade accounts payable 216.6 231.5 Salaries, wages and commissions 107.3 144.7 Deferred income taxes 1.4 1.5 Other accrued liabilities 342.6 331.5 -------- -------- Total Current Liabilities 1,372.0 1,047.5 -------- -------- Long-term debt 1,457.0 1,834.0 Deferred income taxes 23.8 25.2 Post-retirement obligations 194.9 195.5 Other long-term liabilities 96.1 195.5 Commitments and Contingencies
'/>"/>

SOURCE Hospira, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine news :

1. Hospira to Host Conference Call for First-Quarter 2009 Results
2. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
3. Hospira Expands Board of Directors
4. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
5. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
6. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
7. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
8. Hospira Names Ken Meyers to Lead Human Resources
9. Hospira Reports Third-Quarter 2008 Results
10. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
11. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection